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Abstract
Cyclodextrins (CDs) possess cyclic structure having (α-1,4)-linked glucopyra-
nose units making them less vulnerable to enzymatic degradation as than the linear 
dextrins. Commonly used natural CDs are α-CD, β-CD, and ɣ-CD with truncated 
cone-like appearance having lipophilic central cavity and hydrophilic exterior 
surface. The problem of low aqueous solubility of natural CDs can be addressed 
by reacting them with various reagents to produce water-soluble derivatives. CD 
derivatives can be categorized in many ways depending upon their substituents, 
biological activity, polarity, and size. The derivatization of natural CDs produces 
noncrystalline and amorphous forms with higher water solubility that are physically 
and microbiologically stable for prolonged time period. Variety of methods can be 
used to determine average degree of substitution for a modified CD. Dissociation 
by dilution is considered as major release mechanism of drugs from complex. It is 
essential to optimize the amount of CDs for a given preparation because they can 
either retard or promote drug delivery through biological membrane.
Keywords: natural cyclodextrins, cyclodextrin derivatives, inclusion complex,  
poorly soluble drugs
1. Introduction
Cyclodextrins (CDs), first isolated by Antoine in 1891, are categorized as cyclic 
oligosaccharides in which glucose units are repeatedly connected through α-1,4-
glycosidic linkages. Their unique property is the availability of various hydroxyl 
groups that serve as active site to form a variety of derivatives and linkages. CDs 
possess the capability of forming inclusion complexes with various molecules by 
incorporating them in their inner hydrophobic cavity, which not only alters the 
biological and physicochemical properties but also expands their magnitude of 
application [1–3].
Inclusion complexation is basically the formation of hydrogen bonds and Van 
der Waals’ and hydrophobic interactions along with removal of water molecules 
[4, 5]. CDs are getting popular as food additives, owing to their solubilizing and 
protecting properties; they can be effectively used for incorporating vitamins, 
flavors, fragrances, essential oils, and dyes. They not only provide the controlled 
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release of drugs and other incorporated molecules but also mask the obnoxious 
taste and odor [6–9].
The order of water solubility for commonly used cyclodextrins is as follows: 
β-CD (18.5 gL−1) < α-CD (145gL−1) < γ-CD (232 gL−1). The crystal state of natural 
CDs indicates strong molecular bonding (high crystal lattice energy) which in turn 
results in low aqueous solubility. β-CD has limited application as a solubilizing agent 
due to its low aqueous solubility, despite low cost, ease of availability, and appropri-
ate cavity size. The most likely justification of lower solubility of β-CD is inadequate 
hydration by water molecule due to intramolecular hydrogen bond interaction 
offered by optimally arranged secondary hydroxyl groups [10]. Another possible 
elucidation of low aqueous solubility is the formation of aggregates that leads to 
unfavorable interactions with the hydrogen bonded structure of water molecule as 
proposed by Colman and coworkers [11]. β-CD shows Bs-type behavior in phase 
solubility graph when added to the aqueous drug solution or suspension due to 
precipitation of respective CD inclusion complex.
The solubilizing power of parent CDs can be enhanced by adopting many 
different strategies, but the most interesting of them is the derivatization of CDs. 
The hydroxyl groups of CDs can be substituted to yield a variety of derivatives with 
significantly high aqueous solubility [12–14]. This chapter discusses the various 
strategies to functionalize the CDs and the resultant improvement in the aqueous 
solubility of formed complexes.
2. Functionalized CDs
Parent CDs can be modified through structural modifications by incorporating 
hydrophilic moieties that will ultimately result in significant increase in aqueous 
solubility. Furthermore, the inclusion complexes formed by modified CDs have 
higher complexation efficiencies than that of parent CDs. Rekharsky and Inoue 
reported various examples of thermodynamic parameters of inclusion complexes 
involving derivatized CDs [5].
It is noteworthy that derivatization of CDs does not always enhance the 
complexation. The inhibition and promotion of complexation solely depends 
upon the type of substituents. Although the strong electrostatic force of attrac-
tion between the cationic substituents and organic anion was predicted to 
promote complexation, paradoxical effect was observed when the complexation 
of 2-naphthalene sulfonate was reduced with polyamine derivatives of β-CD. An 
unfavorable entropic effect may be involved that results in decrease in com-
plexation [15]. On the other hand, a favorable electrostatic interaction occurs 
that leads to formation of zwitterionic corona by substituting both cationic and 
anionic groups at the primary face that will ultimately enhance the complexation 
of amino acids [16].
The interdependence of numerous molecular parameters including type of 
substituent at the CDs, contribution of hydrophobic, and charge character of the 
guest moiety and competitive self-complexation (possible inclusion complexation 
of substituent moiety inside the core of CD) was discussed in detail by Kean and his 
coworkers [17]. While dealing with ionic species, electrostatic effects are usually 
dominated which exert a paradoxical effect. Based on this status quo, the inclusion 
complexation of charged CD with organic ions must be evaluated on the basis of 
electrostatic interactions. The properties of modified CDs are governed by the loca-
tion of hydroxyl groups on the parent CDs that are going to be substituted. Three 
different hydroxyl groups that exert different reactivities are located on the glucose 
repeating unit of a CD molecule, including one primary hydroxyl group attached to 
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C6 (at the narrow side) and two secondary hydroxyl groups attached to C2 and C3 
(at wider side).
Most common derivatives of CDs are discussed in this section.
2.1 Methyl derivatives of CDs
There is variety of ways to perform methylation of native cyclodextrins:
Formerly methyl derivatives were synthesized by using either methyl iodide 
or dimethyl sulfate [18]. These two reagents are highly toxic and unsafe so may 
be detrimental to the environment as well as human being. Based on this status 
quo, it is mandatory to seek new and novel synthetic method to replace these toxic 
chemicals.
Dimethyl carbonate being eco-friendly could be an attractive alternate in this 
scenario [19]. The synthesis involves addition of β-CD in dimethylformamide 
solution followed by stirring until clear solution is obtained. Potassium carbonate 
is added as catalyst followed by dropwise addition of dimethyl carbonate, and 
mixture is allowed to stir for the next 48 hours. The catalyst and dimethyl carbonate 
are removed to produce syrupy consistency. At the end, this concentrate is treated 
with acetone followed by its removal by filtration. Finally, the product is treated 
with ether two to three times, and after filtration white powdered product is 
obtained as indicated in Figure 1.
An important feature of methyl β-CD is its degree of substitution that has 
marked effect on drug solubilization, so it must be carefully investigated [20]. 
Table 1 gives the use of methyl derivatives of β-CD with effect on solubility and 
efficacy of various drugs.
This pharmaceutically significant methylated derivative of β-CD has the 
following advantages:
• Easy availability (as dry powder/aqueous solution 50%)
• Good water solubility
• Cost-effective
• High inclusion capacity for hydrophobic drugs
2.2 Hydroxypropyl CDs
The replacement of hydroxyl groups of CD by 2-hydroxypropyl moiety can be 
done by the reaction of CD with propylene oxide in an alkaline aqueous solution 
(Figure 2a) [31]. An isopropylene (oligomeric hydroxypropylene) side chain is 
formed for high degree of substitution (Figure 2b).
Figure 1. 
Synthesis of methyl β-CD [21].
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The characterization of finally synthesized hydroxypropyl derivatives involves 
determination of average number of substituents on the cyclodextrin molecule 
(degree of substitution). According to latest US and European pharmacopoeias, 
the acceptable range for DS is 2.8–10.5 for HPβCD. Degree of substitution can be 
measured by a variety of techniques including near-infrared reflectance spectros-
copy, nuclear magnetic resonance (NMR), microcalorimetric titration [33], mass 
spectrometry (MS), differential scanning calorimetry (DSC) [34], and reductive-
cleavage and methylation analysis.
Encapsin™ and Molecusol™ are the trade names of commercially available 
form of hydroxyalkyl derivative (2-hydroxypropyl-β-CD). Various clinical trials 
have been performed with this derivative besides its use in technological, toxico-
logical, and pharmaceutical experiments [35]. Being the most thoroughly studied 
derivative, FDA has approved Sporanox™ by Janssen using the same derivatives 
as molecular carrier. The hydroxypropyl derivative of β-CD and ɣ-CD have been 
widely used for solubility enhancement and leading to increase in efficacy of vari-
ous drugs as illustrated in Tables 2 and 3.
2.3 Sulfoalkylated CDs
Almost more than 180 articles had focused on the preparation and use of charged 
(anionic) CD derivatives by the end of July 1998.The glucopyranose unit present in 
the native CD ring could be directly substituted with charged moiety, or a neutral 
spacer group may be used for the insertion [49]. Such functional groups can be 
inserted at different degrees of substitution (DS) and have variable sizes, so the final 
product of modified CD derivative may be influenced by electronic and steric factors.
The sulfopropyl and sulfobutyl derivatives of beta-CDs are produced by react-
ing native CD with propane sultone and butane sultone, respectively, in an alkaline 
aqueous solution as shown in Figure 3.
Author Drug Additives 
(if used)
Effects
Schipper et al. 
[22]
Insulin — Improved nasal absorption
Schipper et al. 
[23]
Salmon calcitonin — Enhanced nasal penetration
Sigurdsson et al. 
[24]
Dexamethasone — Localized drug delivery to anterior eye 
segment
Soares-Sobrinho 
et al. [25]
Benznidazole PVP, 
HPMC
Enhanced solubility, reduced toxicity
Mathiron et al. 
[26]
Midazolam — Improved solubility, protective effect on 
drug degradation
Chao et al. [27] Ofloxacin — Significant increase in solubility, 
improved pharmacological efficacy
Vieira et al. [28] Efavirenz PVP Improved dissolution profile, increased 
stability
Rassu et al. [29] Deferoxamine 
mesylate
— Improved bioavailability, avoidance of 
systemic exposure
Terauchi et al. 
[30]
Simvastatin — Improved solubility, effective bone 
regeneration therapy
Table 1. 
Effect of methyl derivatives of β-CD on solubility and efficacy of drugs.
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Figure 2. 
Reaction scheme for HPβCD synthesis: (a) low DS, (b) high DS [32].
Author Drug Other additives 
(if present)
Effects
Kaur et al. 2004 
[36]
Acetazolamide PVA, PVP, 
HPMC, 
Carbopol 940
Improved solubility, effective drug 
permeation, improved corneal transport
Chowdary et al. 
[37]
Celecoxib PVP, HPMC, 
PEG
Improved solubility, higher CE by ternary 
complexation
El-Maradny 
et al. [38]
Meloxicam PVP, L-ARG Improved solubility, quick pain relieving 
effect, faster drug release with ternary 
complex
Manali Shah 
et al. [39]
Etoricoxib PVP, L-ARG Enhanced dissolution profile, improved 
oral bioavailability
Asbahr et al. 
[40]
Finasteride PVP, chitosan Positive effect on drug solubility, inc. in 
bulk of formulation so can be used in solid 
dosage forms
Mummidi and 
Jayanthi [41]
Isradipine PVP, HPMC, 
PEG
Marked increase in solubilizing efficiency, 
improved dissolution with ternary 
complexes
Pacheco et al. 
[42]
Albendazole PVA Enhanced solubility, improved intrinsic 
dissolution rate
Jadhav and Pore 
[43]
Bosentan Arginine (ARG) Enhanced solubility and dissolution profile
Table 2. 
Effects of HPβCD on solubility and efficacy of drugs.
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Sulfobutylated β-CD with seven substituents is considered as suitable deriva-
tive and is commercially available under the trade name of Captisol™ by CyDex. 
Resveratrol is complexed with sulfobutylether derivatives of β-CD and increased 
the anticancer activity with increase in solubility of resveratrol as well [51].
2.4 Sulfated CDs
A class of water-soluble CD derivatives having anti-angiogenic, biological, 
and anticancer properties is sulfated CDs. As the tumor growth is dependent on 
angiogenesis, the use of these derivatives could be a unique approach for the treat-
ment of solid tumors, as reported by Folkman et al. in early 1970 [52]. In addition 
to these properties, they also possess antilipemic, antiviral, and anti-inflammatory 
effects [53].
Reaction of CD in absolute dimethylformamide with pyridine sulfur trioxide 
gives better yield of sulfated derivatives of CDs [54]. Besides their use as solubility 
enhancers, these derivatives also provide protection against gentamicin-induced 
nephrotoxicity and have no hemolytic properties, so can be effectively used in 
clinical studies [55]. Figure 4 presents the scheme of preparation of sulfated 
β-CD.
Author Drug Other 
additives  
(if present)
Effects
Zhou et al. [44] Baicalein — Higher drug absorption, better stability, 
enhanced release profile
Soica et al. [45] Oleanolic acid, 
ursolic acid
— Enhanced aqueous solubility, marked 
antiproliferative activity
Misiuk and 
Jasiuk 2014 [46]
Bupropion — Improved release, rapid absorption, 
enhanced encapsulation efficiency
Misiuk et al. 
[47]
Ceftazidime — Improved aqueous solubility, improved 
stability as suggested by NMR study
Wathoni et al. 
[48]
Curcumin — Increased solubility, enhanced antioxidant 
activity
Table 3. 
Effects of HPɣCD on solubility and efficacy of drugs.
Figure 3. 
Synthesis of SBE-β-CD [50].
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2.5 Guidelines regarding synthesis of CD derivatives
The following guidelines should be strictly followed during the synthesis of CD 
derivatives in order to get the better solubility and complexing ability:
• Although the substituents at primary hydroxyl side may influence other uses, 
they do not exert much effect on the complexation. The pH of the medium 
is decisive that either the secondary hydroxyl side or primary side will be 
substituted. Moderately basic medium will favor secondary hydroxyl sub-
stitution, whereas primary hydroxyl side will get substituted in strong basic 
medium [57].
• To avoid the deformation of cavity shape, avoid the bulky substitution which 
may crowd each other. Although the CD torus is made of anhydroglucose 
repeating units which are quite rigid, they are connected to each other through 
single glycosidic bonds. As torus is stabilized by hydrogen bonds between the 
secondary hydroxyls on adjacent glucose unit, the stabilizing effect of hydro-
gen bonding is diminished by secondary hydroxyl substitution. Finally, the 
anhydroglucose units may tilt out the defined torus shape due to introduction 
of steric strain between substituting units present on the adjacent anhydroglu-
cose residues [35].
• The water-soluble CDs are used either in solid form or in concentrated solution 
state. Some substituting groups have the tendency to incorporate in the core of 
CDs, so they compete with active drug molecules for inclusion complexation. 
Therefore, it is mandatory to select those substituents that are unable to fit in 
the cavity of CDs [58].
• A glucopyranose unit of cyclodextrin ring contains how many substituted 
hydroxyl groups are defined as its degree of substitution. One mole of glucopy-
ranose unit contains three reactive hydroxyl groups so the maximum possible 
numbers of substituents are 18, 21, and 24 for α-, β-, and γ- CDs, respectively. 
Controlling the degree of substitution is important in producing the desired 
properties in functionalized CDs.
3. Conclusion
Using different functional groups, modified CDs could play a pivotal role in 
improving limited drug stability and boosting aqueous solubility and dissolution 
behavior of drugs with poor water solubility. In order to use full potential of CDs as 
Figure 4. 
Synthesis of sulfated β-CD [56].
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a drug delivery carrier, the nature and degree of functionalization play an impor-
tant role. However, the future research should focus on the use of green chemistry 
for CDs’ functionalization, and the attention should also be paid to the toxicoki-
netic profiling of the modified CDs to establish their safety and efficacy at the same 
time.
Conflict of interest
There is no conflict of interest among the listed authors.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
9Effect of Cyclodextrin Derivatization on Solubility and Efficacy of Drugs
DOI: http://dx.doi.org/10.5772/intechopen.90364
References
[1] Kurkov SV, Loftsson T. Cyclodextrins. 
International Journal of Pharmaceutics. 
2013;453:167-180. DOI: 10.1016/j.
ijpharm.2012.06.055
[2] Brewster ME, Loftsson T.  
Cyclodextrins as pharmaceutical 
solubilizers. Advanced Drug Delivery 
Reviews. 2007;59:645-666. DOI: 
10.1016/j.addr.2007.05.012
[3] Del Valle EM. Cyclodextrins and their 
uses: A review. Process Biochemistry. 
2004;39:1033-1046. DOI: 10.1016/
S0032-9592(03)00258-9
[4] Acuña-Rougier C, Olea-Azar C. 
Thermodynamic and geometric study 
of diasteroisomeric complexes formed 
by racemic flavanones and three 
cyclodextrins through NMR. Journal of 
Inclusion Phenomena and Macrocyclic 
Chemistry. 2013;75:119-136. DOI: 
10.1007/s10847-012-0153-5
[5] Rekharsky MV, Inoue Y. Complexation 
thermodynamics of cyclodextrins. 
Chemical Reviews. 1998;98:1875-1918. 
DOI: 10.1021/cr970015o
[6] Astray G, Gonzalez-Barreiro C, 
Mejuto JC, Rial-Otero R, Simal-Gandara J. A 
review on the use of cyclodextrins 
in foods. Food Hydrocolloids. 
2009;23:1631-1640. DOI: 10.1016/j.
foodhyd.2009.01.001
[7] Szente L, Szejtli J. Cyclodextrins 
as food ingredients. Trends in Food 
Science and Technology. 2004;15:137-
142. DOI: 10.1016/j.tifs.2003.09.019
[8] Szejtli J, Szente L. Elimination of 
bitter, disgusting tastes of drugs and 
foods by cyclodextrins. European 
Journal of Pharmaceutics and 
Biopharmaceutics. 2005;61:115-125. 
DOI: 10.1016/j.ejpb.2005.05.006
[9] Loftsson T, Brewster ME, Masson M. 
Role of cyclodextrins in improving oral 
drug delivery. American Journal of 
Drug Delivery. 2004;2:261-275. DOI: 
10.2165/00137696-200402040-00006
[10] Miyazawa I, Ueda H, Nagase H,  
Endo T, Kobayashi S, Nagai T.  
Physicochemical properties and 
inclusion complex formation 
of δ-cyclodextrin. European 
Journal of Pharmaceutical 
Sciences. 1995;3:153-162. DOI: 
10.1016/0928-0987(95)00006-Y
[11] Coleman AW, Nicolis I, Keller N, 
Dalbiez JP. Aggregation of cyclodextrins: 
An explanation of the abnormal 
solubility of β-cyclodextrin. Journal of 
Inclusion Phenomena and Molecular 
Recognition in Chemistry. 1992;13:139-
143. DOI: 10.1007/BF01053637
[12] Szejtli J. The properties and 
potential uses of cyclodextrin 
derivatives. Journal of Inclusion 
Phenomena and Molecular Recognition 
in Chemistry. 1992;14:25-36. DOI: 
10.1007/BF01041363
[13] Uekama K. Pharmaceutical 
uses of cyclodextrin derivatives. In: 
High Performance Biomaterials. A 
Comprehensive Guide to Medical 
and Pharmaceutical Applications. 
Szycher M, editor. Technomic: 
Lancaster, PA; 1991. pp. 789-806
[14] Szejtli J. Introduction and general 
overview of cyclodextrin chemistry. 
Chemical Reviews. 1998;98:1743-1754. 
DOI: 10.1021/cr970022c
[15] Inoue Y, Liu Y, Tong LH, Shen BJ,  
Jin DS. Calorimetric titration of 
inclusion complexation with modified. 
Beta.-cyclodextrins. Enthalpy-
entropy compensation in host-guest 
complexation: From ionophore to 
cyclodextrin and cyclophane. Journal 
of the American Chemical Society. 
1993;115:10637-10644. DOI: 10.1021/
ja00076a023
Colloid Science in Pharmaceutical Nanotechnology
10
[16] Tabushi I, Kuroda Y, Mizutani T. 
Artificial receptors for amino acids in 
water. Local environmental effect on polar 
recognition by 6A-amino-6B-carboxy-
and 6B-amino-6A-carboxy-. Beta.-
cyclodextrins. Journal of the American 
Chemical Society. 1986;108:4514-4518. 
DOI: 10.1021/ja00275a043
[17] Kean SD, May BL, Clements P,  
Lincoln SF, Easton CJH. Host–guest 
complexation of aromatic carboxylic 
acids and their conjugate bases by 6 
A-(ω-aminoalkylamino)-6 A-deoxy-
β-cyclodextrins† in aqueous solution. 
Journal of the Chemical Society, Perkin 
Transactions. 1999;2:1257-1264. DOI: 
10.1039/A806488A
[18] Yuan LM. Effect of mobile 
phase additive on chiral separation. 
Separation and Purification Technology. 
2008;63:701-705. DOI: 10.1016/j.
seppur.2008.06.021
[19] Tundo P, Selva M. The chemistry 
of dimethyl carbonate. Accounts of 
Chemical Research. 2002;35:706-716. 
DOI: 10.1021/ar010076f
[20] Gan Y, Zhang Y, Xiao C, Zhou C, 
Zhao Y. A novel preparation of methyl-
β-cyclodextrin from dimethyl carbonate 
and β-cyclodextrin. Carbohydrate 
Research. 2011;346:389-392. DOI: 
10.1016/j.carres.2010.05.028
[21] Available from: http://www.google.
com/search?biw=1366&bih=576&tbm
=isch&sa=1&ei=PgvvXICpLZHFwQK
JgK-YAQ&q=synthesis+of+ 
methyl+%CE%B2-Cyclodextrin
&oq=synthesis+of+methyl+%C
E%B2-Cyclodextrin&gs 1=img.3…
165667.172378..178711…o.o..o.358.2515.
ojij5j3......o....1j2..gws-wiz-img…….
ojoi67.kdloQir1DqM#imgrc=qywHXUG
YUQO96M:
[22] Schipper NG, Romeijn SG, 
Verhoef JC, Merkus FW. Nasal insulin 
delivery with dimethyl-β-cyclodextrin 
as an absorption enhancer in rabbits: 
Powder more effective than liquid 
formulations. Pharmaceutical 
Research. 1993;10:682-686. DOI: 
10.1023/A:1018999414088
[23] Schipper NG, Verhoef JC, 
Romeijn SG, Merkus FW. Methylated 
β-cyclodextrins are able to improve the 
nasal absorption of salmon calcitonin. 
Calcified Tissue International. 
1995;56:280-282. DOI: 10.1007/
BF00318047
[24] Sigurdsson HH, Konráðsdóttir F, 
Loftsson T, Stefansson E. Topical 
and systemic absorption in 
delivery of dexamethasone to the 
anterior and posterior segments of 
the eye. Acta Ophthalmologica 
Scandinavica. 2007;85:598-602. DOI: 
10.1111/j.1600-0420.2007.00885.x
[25] Soares-Sobrinho JL, Santos FL,  
Lyra MA, Alves LD, Rolim LA, 
Lima AA, et al. Benznidazole drug 
delivery by binary and multicomponent 
inclusion complexes using cyclodextrins 
and polymers. Carbohydrate Polymers. 
2012;89:323-330. DOI: 10.1016/j.
carbpol.2012.02.042
[26] Mathiron D, Marçon F, Dubaele JM, 
Cailleu D, Pilard S, DjedaÏni-pilard 
F. Benefits of methylated cyclodextrins 
in the development of midazolam 
pharmaceutical formulations. 
Journal of Pharmaceutical Sciences. 
2013;102:2102-2111. DOI: 10.1002/
jps.23558
[27] Chao J, Liu Y, Zhang Y, Zhang J, 
Zhang Y, Guo Z, et al. Investigation 
of the inclusion behavior of ofloxacin 
with methyl-β-cyclodextrin. Journal of 
Molecular Liquids. 2014;200:404-409. 
DOI: 10.1016/j.molliq.2014.11.015
[28] Vieira AC, Fontes DA, Chaves LL, 
Alves LD, de Freitas Neto JL, Soares MF, 
et al. Multicomponent systems with 
cyclodextrins and hydrophilic 
polymers for the delivery of Efavirenz. 
Carbohydrate Polymers. 2015;130:133-
140. DOI: 10.1016/j.carbpol.2015.04.050
11
Effect of Cyclodextrin Derivatization on Solubility and Efficacy of Drugs
DOI: http://dx.doi.org/10.5772/intechopen.90364
[29] Rassu G, Soddu E, Cossu M, 
Brundu A, Cerri G, Marchetti N, et al. 
Solid microparticles based on chitosan 
or methyl-β-cyclodextrin: A first 
formulative approach to increase the 
nose-to-brain transport of deferoxamine 
mesylate. Journal of Controlled 
Release. 2015;201:68-77. DOI: 10.1016/j.
jconrel.2015.01.025
[30] Terauchi M, Inada T, Tonegawa A, 
Tamura A, Yamaguchi S, Harada K, et al. 
Supramolecular inclusion complexation 
of simvastatin with methylated 
β-cyclodextrins for promoting 
osteogenic differentiation. International 
Journal of Biological Macromolecules. 
2016;93:1492-1498. DOI: 10.1016/j.
ijbiomac.2016.01.114
[31] Pitha J, Szabo L, Fales HM. Reaction 
of cyclodextrins with propylene 
oxide or with glycidol: Analysis of 
product distribution. Carbohydrate 
Research. 1987;168:191-198. DOI: 
10.1016/0008-6215(87)80025-3
[32] Available from: http://www.google.
com/search?q=Reaction+scheme+for+H
PBCD+synthesis&source=Inms&tbm=i
sch&sa=X&ved=oahUKEwiY- 
Lj 6cHiAhXBoKQKHdfkBGkQ 
AUIDigB&biw=1366&bih=576# 
imgrc=fwlmslwWc6M3DM:
[33] Reer O, Müller BW. Determination 
of the degree of substitution of 
chemically modified cyclodextrins 
by a microcalorimetric titration 
technique. International Journal of 
Pharmaceutics. 1994;104:239-246. DOI: 
10.1016/0378-5173(94)90164-3
[34] Novák C, Pokol G, Sztatisz J, 
Szente L, Szejtli J. Determination of 
the degree of substitution of 
hydroxypropylated β-cyclodextrins 
by differential scanning 
calorimetry. Analytica Chimica 
Acta. 1993;282:313-316. DOI: 
10.1016/0003-2670(93)80216-8
[35] Szente L, Szejtli J. Highly soluble 
cyclodextrin derivatives: Chemistry, 
properties, and trends in development. 
Advanced Drug Delivery Reviews. 
1999;36:17-28. DOI: 10.1016/
S0169-409X(98)00092-1
[36] Kaur IP, Kapil M, Smitha R, 
Aggarwal D. Development of topically 
effective formulations of acetazolamide 
using HP-β-CD-polymer co-complexes. 
Current Drug Delivery. 2004;1:65-72. 
DOI: 10.2174/1567201043480054
[37] Chowdary KP, Srinivas SV. 
Influence of hydrophilic polymers 
on celecoxib complexation with 
hydroxypropyl β-cyclodextrin. AAPS 
PharmSciTech. 2006;7:E184-E189. DOI: 
10.1208/pt070
[38] El-Maradny H, Mortada S, Kamel O, 
Hikal A. Characterization of ternary 
complexes of meloxicam-HPβCD 
and PVP or L-arginine prepared by 
the spray-drying technique. Acta 
Pharmaceutica. 2008;58:455-466. DOI: 
10.2478/v10007-008-0029-9
[39] Shah M, Karekar P, Sancheti P, 
Vyas V, Pore Y. Effect of PVP K30 and/
or L-arginine on stability constant of 
etoricoxib–HPβCD inclusion complex: 
Preparation and characterization of 
etoricoxib–HPβCD binary system. 
Drug Development and Industrial 
Pharmacy. 2009;35:118-129. DOI: 
10.1080/03639040802220292
[40] Asbahr AC, Franco L, Barison A,  
Silva CW, Ferraz HG, Rodrigues LN. 
Binary and ternary inclusion complexes 
of finasteride in HPβCD and polymers: 
Preparation and characterization. 
Bioorganic & Medicinal Chemistry. 
2009;17:2718-2723. DOI: 10.1016/j.
bmc.2009.02.044
[41] Mummidi V, Jayanthi V. Effect 
of hydrophilic polymers on 
isradipine complexation with 
hydroxypropyl β-cyclodextrin. 
Drug Development and Industrial 
Pharmacy. 2013;39:970-977. DOI: 
10.3109/03639045.2012.686508
Colloid Science in Pharmaceutical Nanotechnology
12
[42] Pacheco PA, Rodrigues LN, 
Ferreira JF, Gomes AC, Veríssimo CJ, 
Louvandini H, et al. Inclusion complex 
and nanoclusters of cyclodextrin to 
increase the solubility and efficacy of 
albendazole. Parasitology Research. 
2018;117:705-712. DOI: 10.1007/s0043
[43] Jadhav P, Pore Y. Physicochemical, 
thermodynamic and analytical 
studies on binary and ternary 
inclusion complexes of bosentan 
with hydroxypropyl-β-cyclodextrin. 
Bulletin of Faculty of Pharmacy, Cairo 
University. 2017;55:147-154. DOI: 
10.1016/j.bfopcu.2016.12.004
[44] Zhou Q , Zhong L, Wei X, Dou W,  
Chou G, Wang Z. Baicalein and 
hydroxypropyl-γ-cyclodextrin complex 
in poloxamer thermal sensitive hydrogel 
for vaginal administration. International 
Journal of Pharmaceutics. 2013;454:125-
134. DOI: 10.1016/j.ijpharm.2013.07.006
[45] Soica C, Oprean C, Borcan F,  
Danciu C, Trandafirescu C, 
Coricovac D, et al. The synergistic 
biologic activity of oleanolic and ursolic 
acids in complex with hydroxypropyl-γ-
cyclodextrin. Molecules. 2014;19:4924-
4940. DOI: 10.3390/molecules19044924
[46] Misiuk W, Jasiuk E. Study of 
the inclusion interaction of HP-γ-
cyclodextrin with bupropion and 
its analytical application. Journal of 
Molecular Structure. 2014;1060:272-279. 
DOI: 10.1016/j.molstruc.2013.12.056
[47] Misiuk W. Investigation of inclusion 
complex of HP-γ-cyclodextrin with 
ceftazidime. Journal of Molecular 
Liquids. 2016;224:387-392. DOI: 
10.1016/j.molliq.2016.10.009
[48] Wathoni N, Motoyama K,  
Higashi T, Okajima M, Kaneko T, 
Arima H. Enhancement of curcumin 
wound healing ability by complexation 
with 2-hydroxypropyl-γ-cyclodextrin 
in sacran hydrogel film. International 
Journal of Biological Macromolecules. 
2017;98:268-276. DOI: 10.1016/j.
ijbiomac.2017.01.144
[49] Rajewski RA. Development 
and evaluation of the usefulness 
and parenteral safety of modified 
cyclodextrins. 5332-5332. Order No. 
DA9110909 from: Diss Abstr Int B; 1991
[50] Available from: http://www.google.
com/search?q=synthesis+of+SBE-
%CE%B2-CD&source=Inms&tbm=isch
&sa=X&ved=oahUKEwjWytO6sHiAhV
Fr6QKHYXyDXoQAUIDigB&biw=1366
&bih=576#imgrc=gsB7mNy3Gv4-EM:
[51] Venuti V, Cannavà C, Cristiano MC, 
Fresta M, Majolino D, Paolino D, et al. 
A characterization study of resveratrol/
sulfobutyl ether-β-cyclodextrin 
inclusion complex and in vitro 
anticancer activity. Colloids and 
Surfaces. B, Biointerfaces. 2014;115:22-
28. DOI: 10.1016/j.colsurfb.2013.11.025
[52] Folkman J, Weisz PB, 
Joullie MM, Li WW, Ewing WR. Control 
of angiogenesis with synthetic heparin 
substitutes. Science. 1989;243:1490-
1493. DOI: 10.1126/science.2467380
[53] Anand R, Nayyar S, Pitha J,  
Merril CR. Sulphated sugar 
alpha-cyclodextrin sulphate, a 
uniquely potent anti-HIV agent, 
also exhibits marked synergism 
with AZT, and lymphoproliferative 
activity. Antiviral Chemistry and 
Chemotherapy. 1990;1:41-46. DOI: 
10.1177/095632029000100107
[54] Pitha J, Mallis LM, Lamb DJ, 
Irie T, Uekama K. Cyclodextrin sulfates: 
Characterization as polydisperse and 
amorphous mixtures. Pharmaceutical 
Research. 1991;8:1151-1154. DOI: 
10.1023/A:1015854402122
[55] Shiotani K, Irie T, Uekama K,  
Ishimaru Y. Cyclodextrin sulfates in 
parenteral use: Protection against 
gentamicin nephrotoxicity in the rat. 
European Journal of Pharmaceutical 
13
Effect of Cyclodextrin Derivatization on Solubility and Efficacy of Drugs
DOI: http://dx.doi.org/10.5772/intechopen.90364
Sciences. 1995;3:139-151. DOI: 
10.1016/0928-0987(95)00008
[56] Available from: http://www.google.
com/search?biw=1366&bih=576&tb
m=isch&sa=1&ei=DA7vXI3jAcPUsA
fFxbqwDw&q=synthesis+of+sulfate
d+beta+Cyclodextrin&oq=synthesis
+of+sulfated+beta+Cyclodextrin&gs 
1=img.3…98943.106317..106999…
o.o..o.287.2376.oj5j6……o….1j2..
gws-img…….35i39jo.-K9CA2MG-
vc#imgrc=HuSGnVpvSKSLsM:
[57] Pitha J, Rao CT, Lindberg B, 
Seffers P. Distribution of substituents 
in 2-hydroxypropyl ethers of 
cyclomaltoheptaose. Carbohydrate 
Research. 1990;200:429-435. DOI: 
10.1016/0008-6215(90)84208-C
[58] Harata K, Rao CT, Pitha J,  
Fukunaga K, Uekama K. Crystal 
structure of 2-O-[(S)-2-hydroxypropyl] 
cyclomaltoheptaose. Carbohydrate 
Research. 1991;222:37-45. DOI: 
10.1016/0008-6215(91)89004-Y
